The AMA's support comes just after the Senate hammered out a major compromise that means the bill is almost certain to pass.

  The doctor who ran the CDC from 2002 until 2009 will head Merck's $5 billion vaccine business.

  The case involves a drug used to enhance images on MRI scans.

  With drugs representing tens of billions of dollars of annual revenues set to lose patent protection in the next few years, the steady revenues of boring, reliable products may seem pretty appealing to drug company CEOs.

  A key element of the Senate compromise on health insurance wouldn't have much of an effect, CBO said.

  There are a few noteworthy health-care provisions buried deep within the $626 billion defense spending bill the Senate’s expected to pass this weekend.

  A third of the hospital's physicians traveled to Hawaii for education courses; few stayed in California.

  Amgen is betting its future on a single bone drug.

  A drug approved to treat cancer and used to de-worm animals is being added to the nation's cocaine supply.

  That's about 150 scripts a day, seven days a week.